Navigation Links
Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
Date:5/8/2009

and drive expansion of the distribution network. We can now measure the successful results of this strategy through the increased number of orders we received. The funds from this new private placement will help us fill the orders we received for our upcoming busy season, the second and third quarters of the year," said Mr. Zishen Wu, CEO of Yongye Biotechnology International, Inc.

The securities issued in the private placement are not registered under the United States Securities Act of 1933 or the securities laws of any other jurisdiction. Accordingly, these securities may not be sold by investors in the United States, except pursuant to an effective registration statement or an applicable exemption from the registration requirements. For more detailed information on this financing, see the Company's Current Report on Form 8-K which will be filed with the Securities and Exchange Commission on or about May 8, 2009.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development and distribution of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

Forward Looking Statements

Certain statements set forth in this press release constitute "Forward- looking statement
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
2. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
3. Yongye Biotechnology Appoints New Chief Financial Officer
4. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
5. Yongye Biotechnology to Host Virtual Retail Road Show to Provide Overview of the Company in English and Mandarin
6. Yongye Biotechnology International to Expand its Network of Branded Stores
7. Yongye Biotechnology to Present at Roth Conference
8. Yongye Biotechnology Announces Record Third Quarter Results
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
11. Yongye Biotechnology International Raises $9.4 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 PrimeSource Building ... materials, selected SoundConnect to support their ... based audio and web conferencing platform GlobalMeet powered ... PrimeSource’s employees’ needs. SoundConnect delivers award winning ... PrimeSource Building Products will be utilizing GlobalMeet ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
(Date:8/27/2014)... August 27, 2014 The Global and ... study on the current state of the Trifluoroacetic Acid ... a basic overview of the industry, including definitions, applications ... domestic market analysis are provided with a focus on ... A comparison between the international and Chinese situation is ...
(Date:8/27/2014)... August 27, 2014 “We are honored ... vendors,” said Ven Thangaraj, CEO of Radiant Sage. “We ... are taking the imaging corelab market to a different ... and research organizations to efficiently and effectively manage the ... data to be analyzed and read by trained physicians. ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Rhythm Files Registration Statement for Proposed Initial Public Offering 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2
... CRY ), a,biomaterials, medical device and tissue processing ... the FBR Capital Markets Annual,Spring Investor Conference, Thursday, May ... City., Steven G. Anderson, president and chief executive ... Time., CryoLife,s live presentation may be accessed through ...
... May 28 /Xinhua-PRNewswire-FirstCall/ -- AMAG,Pharmaceuticals, Inc. (Nasdaq: ... SSRX ), a,leading Chinese biotechnology company, ... commercialization agreement for ferumoxytol, an intravenous,iron replacement ... deficiency,anemia in chronic kidney disease (CKD) patients., ...
... May 27 CellCyte Genetics,Corporation (CellCyte) (OTC ... provide shareholders, potential investors and journalists,with accurate ... Room powered Web site: http://www.cellcyte.com ... or sources for stories from,CellCyte can access ...
Cached Biology Technology:CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference 2AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 2AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 3
(Date:8/27/2014)... willing to pay a premium for fruits, vegetables and ... the label claims is another matter. Now scientists studying ... to make sure farms are labelling their produce appropriately. ... Agricultural and Food Chemistry , could help prevent organic ... Food Safety Authority and the Wuerzburg University note that ...
(Date:8/27/2014)... studies have shown that excessive iron is ... disease. Previous studies from Chunyan Guo and ... have shown that baicalin prevented iron accumulation ... transporter 1 expression, and increased ferroportin 1 ... Parkinson,s disease rats. However, the relationship between ...
(Date:8/27/2014)... of Warwick research finds , Gamblers show the ... new research has shown. , Researchers, led by Dr ... Psychology, conducted tests that found that both human gamblers ... high-value than low-value rewards. , Published in Biology ... show the important role that memories of previous biggest ...
Breaking Biology News(10 mins):Gamblers are greedy bird-brains, University of Warwick research finds 2
... Unlike most of our sensory systems that detect only one ... detecting both chemical and mechanical stimuli to improve how we ... in the March issue of Nature Neuroscience. , This ... reaction in olfactory nerve cells, which control how our brain ...
... the University of Liverpool have found how two molecules fight ... , Researchers discovered that a large protein, which forms a ... secondary tumours, is attacked by a small protein that exists ... breast, lung and colorectal cancer, infected cells lose growth control ...
... onset of type 1 diabetes in mice prone to ... on the surface of immune T-cells. According to the ... January issue of the journal Diabetes, have significant implications ... More than 700,000 Americans have type 1 diabetes, an ...
Cached Biology News:Penn study on olfactory nerve cells shows why we smell better when we sniff 2Scientists discover how body fights to control spread of cancer 2Antibody therapy prevents type 1 diabetes in mice 2